The Cancer Letter
Podcast Description
The Cancer Letter, an independent weekly news publication, has been the leading source for information on the issues that shape oncology since 1973.
With a dedicated audience of oncology’s leaders, The Cancer Letter stays on top of breaking news and advances in oncology, providing authoritative, award-winning coverage of the development of cancer therapies, drug regulation, legislation, cancer research funding, health care finance, and public health.
This weekly podcast features interviews, discussions, and more to dig deep into the issues that shape oncology.
Podcast Insights
Content Themes
Covers vital themes in oncology including cancer therapies, drug regulation, cancer research funding, and public health, with episodes discussing topics like cancer incidence rates, the impact of government policies on federal health employees, and significant scientific discoveries such as the EGFR mutation in lung cancer.
The Cancer Letter, an independent weekly news publication, has been the leading source for information on the issues that shape oncology since 1973.
With a dedicated audience of oncology’s leaders, The Cancer Letter stays on top of breaking news and advances in oncology, providing authoritative, award-winning coverage of the development of cancer therapies, drug regulation, legislation, cancer research funding, health care finance, and public health.
This weekly podcast features interviews, discussions, and more to dig deep into the issues that shape oncology.
“Patients are counting on us, and this remains the best time to be involved in cancer research,” W. Kimryn Rathmell said to The Cancer Letter.
Rathmell spoke with The Cancer Letter’s Paul Goldberg on her first day as CEO of The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
“We can now study, in patients, things that previously before we could only try to guess at that,” Rathmell said. “There are discoveries we can make in real time that will change and impact patients like next year and the year after, not decades from now, not in another generation.”
In this episode of In the Headlines, Paul Goldberg, editor of The Cancer Letter, and Jacquelyn Cobb, associate editor, call in from the American Society of Clinical Oncology annual meeting to discuss the happenings at the meeting, Paul’s conversation with Rathmell—and FDA’s empty booth.
Rathmell encouraged young investigators to stay the course.
“Money may be scarce, but the ideas are not,” Rathmell said. “There are great ideas out there. I would encourage anyone who is interested in this career path to really double down. Really, the boldest ideas are the ones that are going to be funded, and to do innovative work and to be enthusiastic about the work that they're doing.”
Stories mentioned in this podcast include:
We catch up with Kimryn Rathmell on her first day as CEO at OSUCCC – James
The other side of the patient portal: Reflections from a cancer center leader, writes Ruben Mesa
Boris Pasche: Surviving cancer is often not a patient’s most challenging battle
A transcript of this podcast is available: https://cancerletter.com/podcastc/20250604-rathmell/
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.